Active Member
|
[China]
Address: No.1 Zhangba Road, Gaoxin District,Xi’an Shaanxi, China
Contact name:zhao
Complex Nature Biotechnology CO., LTD. |
|
Medicine Grade schisandra chinensis extract for capsule
product details
1.Product Name: Nature Schisandra Seed Oil
2.Latin name:Schisandra chinensis (Turcz.) Baill fruits
3.Extract source:Seed
4. The Main Component Of:Schisandrin>2.2%
5.Appearance:Light Yellow
Product Description
Schisandra chinensis Baill. (Schisandraceae/Magnoliaceae) is a famous medicinal plant native to East Asia. It grows wild mainly in the most Eastern parts of Russia, the Kuril Islands, southern Sachalin and also north-eastern China, Korea and Japan. The idenbiologically active compounds are the lignans with an uncommon structure derived from dibenzo cyclooctadiene. The lignans prevent liver injuries stimulate liver regeneration [5]and also inhibit hepatocarcinogenesis and lipid peroxidation. Moreover, several reports indicate that the lignans have effects on human intellectual activity and physical performance. Recently, some dibenzo cyclooctadiene lignans were identified as potent anti-human immunodeficiency virus agent. schisandra oil
Product Analysis
| Item | Specification | Result | Method |
| BasicProduct Information | |||
| Product name | schisandra chinensis extract | ||
| Part of the Plant | seed | Conform | / |
| Country of Origin | China | Conform | / |
| Organoleptic Data | |||
| Appearance | Fine powder | Conform | NLS-QCS-1008 |
| Color | light yellow Powder | Conform | GB/T 5492-2008 |
| Odor& Taste | Characteristic | Conform | GB/T 5492-2008 |
| Process Data | |||
| Solvent(s) Used | Water and ethyl alcohol | Conform | / |
| Extract ration | 10:1 | Conform | |
| Content | / | / | |
| Drying Method | Spray drying | Conform | / |
| Excipient | Maltodextrin | Conform | / |
| Physical Characteristics | |||
| Particle Size (80 mesh) | 98.0%pass 80mesh | Conform | GB/T 5507-2008 |
| Moisture | <5.0% | 2.8% | GB/T 14769-1993 |
| Ash Content | <4.0% | 1.4% | AOAC 942.05, 18th |
| Solvent Residue | Eur. Pharm | Conform | NLS-QCS-1007 |
| Heavy Metals | |||
| Total Heavy Metals | <10 ppm | Conform | USP <231>, method II |
| Arsenic | <1.0 ppm | Conform | AOAC 986.15, 18th |
| Lead | <1.0 ppm | Conform | AOAC 986.15, 18th |
| Mercury | <0.5 ppm | Conform | AOAC 971.21, 18th |
| Pesticide Residue | |||
| 666 | <0.2ppm | Conform | GB/T5009.19-1996 |
| DDT | <0.2ppm | Conform | GB/T5009.19-1996 |
| Microbiology | |||
| Total Plate Count | <1,000cfu/g | 17cfu/g | AOAC 990.12, 18th |
| Total Yeast & Mold | <100cfu/g | 3cfu/g | FDA (BAM) Chapter 18, 8th Ed. |
| E. Coli | Negative | Negative | AOAC 997.11, 18th |
| Salmonella | Negative | Negative | FDA (BAM) Chapter 5, 8th Ed. |
Product Function
1. Visceral hyperalgesia
2. Immunomodulatory effects
3. Antioxidant activity
4. Colon cancer
5. Leukemia
6. Cardioprotective effects
7. Atopic Dermatitis
8. Relaxant effects
